X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF CLINICAL ONCOLOGY

期刊標題檢索 J CLIN ONCOL 最新評論: The submission period usually falls between 3-6 months, so your three... (2024-10-26)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF CLINICAL ONCOLOGY]您好,您是該頁面的第 93540 位訪客。

期刊簡介
期刊名稱JOURNAL OF CLINICAL ONCOLOGY JOURNAL OF CLINICAL ONCOLOGY
LetPub Score
9.9
50 ratings
Rate

Reputation
9.9

Influence
9.9

Speed
9.1

期刊簡稱J CLIN ONCOL
ISSN0732-183X
E-ISSN1527-7755
h-index494
CiteScore
CiteScoreSJRSNIPCiteScore Rank
41.2010.6396.162
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q19 / 404
Category: Medicine
Subcategory: Cancer Research
Q16 / 230

自引率 (2023-2024)2.40%自引率趨勢
掲載範囲
The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.

Print ISSN: 0732-183X
官方網站http://jco.ascopubs.org/
在線稿件提交https://www.editorialmanager.com/JCO-ASCOPUBS
開放訪問No
出版商American Society of Clinical Oncology
主題領域医学
出版國/地區UNITED STATES
發行頻率隔週刊行
創刊年1983
每年文章數479每年文章數趨勢
黃金OA百分比29.96%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ16/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0732-183X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 20%
參考鏈接
相關期刊 【JOURNAL OF CLINICAL ONCOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    CLINICAL CANCER RESEARCHH-index: 292

    CiteScore: 20.10
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS330958
    CANCER RESEARCH312133
    BMC CANCER245497
    Asian Pacific Journal of Cancer Prevention219198
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198015
    INTERNATIONAL JOURNAL OF CANCER191629
    CLINICAL CANCER RESEARCH181666
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176404
    ONCOLOGY REPORTS175031
    CA-A CANCER JOURNAL FOR CLINICIANS163632
  •  

    JOURNAL OF CLINICAL ONCOLOGY JOURNAL OF CLINICAL ONCOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [JOURNAL OF CLINICAL ONCOLOGY] 的評論撰寫評論
作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-26 19:23:11 評論於
The submission period usually falls between 3-6 months, so your three months is also normal.
(0) 讚! | Adelaide Lawson

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-26 08:53:39 評論於
It may be a browser issue, field highlighting issue, system setting issue, or even a formatting issue. If you have made sure that all required fields are correctly filled in and still encounter the problem, try registering with a different browser. If the issue persists, you can contact the journal's editorial office or technical support for assistance.
(0) 讚! | Adelaide Lawson

作者: 平原依凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-01 09:34:21 評論於
Why does it keep saying "Please correct the highlighted fields below." when I've filled in all the required fields? Help!!!
(0) 讚! | 平原依凝

作者: 一只小鲤鱼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-25 17:58:14 評論於
I received a "Decision in Process" status just two days after submitting my paper. It has been four days now and I have not received a rejection notice yet. Did you also have a "Decision in Process" stage when you submitted your paper?
(0) 讚! | 一只小鲤鱼

作者: bosy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-23 18:56:53 評論於
How are you doing?
(0) 讚! | bosy

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-19 12:14:27 評論於
Review speed: 3.0 | Submission hit rate: 25.0 Emphasis on research directions: ASCO; tumor; solid tumor Experience sharing: JOURNAL OF CLINICAL ONCOLOGY, 2023 impact factor is 42.1 points, which is basically the same as LANCET ONCOLOGY, they are on par, and still in a leading position in the field of oncology. LANCET ONCOLOGY has an impact factor of 41.6 in 2023, which is overall good. CA-A CANCER JOURNAL FOR CLINICIANS, 503.1, dominates with one article, without considering Nature Reviews Clinical Oncology 81.3, mainly publishing reviews, ANNALS OF ONCOLOGY, 56.7 mainly reviews CANCER CELL 48.8, mainly publishes translational medicine, of course, starting from the past two years, also published a few clinical trial articles. Moving down, Cancer Discovery, 29.7, also publishes articles on basic research and translational medicine, which are far from clinical. Journal of Hematology & Oncology 29.5 is a comprehensive journal on hematologic tumors and solid tumors, impressive Molecular Cancer 27.7 is also related to tumor translational medicine.
(0) 讚! | 是志丹吖

作者: 西域妙绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-06 13:00:17 評論於
How long have you been under review?
(0) 讚! | 西域妙绿

作者: 西域妙绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-28 11:02:25 評論於
29 days left
(0) 讚! | 西域妙绿

作者: 西域妙绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-25 13:14:29 評論於
26 days to go, keep it up! ?
(0) 讚! | 西域妙绿

作者: 西域妙绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-16 14:44:19 評論於
Under review for 17 days
(0) 讚! | 西域妙绿

作者: 西域妙绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-05 16:31:08 評論於
Focused research direction: Tumor clinical experience sharing: Under review for 7 days, hoping for good luck ??
(0) 讚! | 西域妙绿

作者: 雨双Sama


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-29 23:52:53 評論於
Is Under Review done by external audit?
(0) 讚! | 雨双Sama

作者: 光明谷玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-15 22:20:19 評論於
Have you successfully registered in the highlighted area?
(0) 讚! | 光明谷玉

作者: 光明谷玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-15 12:11:23 評論於
Have you successfully registered?
(0) 讚! | 光明谷玉

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-29 17:18:36 評論於
Review speed: 3.0 | Submission hit rate: 25.0
Emphasized research directions: Lung cancer; Breast cancer; Colorectal cancer
Experience sharing: Impact Factor 45.3 in 2023, slightly lower than Lancet Oncology, which is at a normal level!!
(0) 讚! | 是志丹吖

作者: 幽花碧霜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-27 20:10:00 評論於
Pretty high priority, no procrastination
(0) 讚! | 幽花碧霜

作者: 稻妻怜蕾


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-27 19:09:54 評論於
Is it?
(0) 讚! | 稻妻怜蕾

作者: Humphrey Senior


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-13 11:29:59 評論於
Does it mean a rejection if there is no "under review" status?
(0) 讚! | Humphrey Senior

作者: 一吃就胖小恨蕊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-04 18:43:43 評論於
How long does it take for your manuscript to be reviewed?
(0) 讚! | 一吃就胖小恨蕊

作者: 北风爱梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-22 13:06:35 評論於
Endure for four days, do not reject the manuscript, and you will succeed
(0) 讚! | 北风爱梅

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-11 08:51:00 評論於
JCO still focuses on conducting trials
(0) 讚! | 是志丹吖

作者: 浩博小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-07 11:00:31 評論於
Why hasn't the status of the letter I submitted changed after a week?
(0) 讚! | 浩博小哥哥

作者: 浩博小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-04 15:26:13 評論於
Why does the status of this submission not change?
(0) 讚! | 浩博小哥哥

作者: Gabriel Joule


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-09 16:10:04 評論於
Hello, do you know how to solve this? I always get a prompt to modify the highlighted area when I register
(0) 讚! | Gabriel Joule

作者: 韦陀飞虎


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-05 13:46:35 評論於
Can I leave a review?
(0) 讚! | 韦陀飞虎

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [JOURNAL OF CLINICAL ONCOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*